|
|
|
|
|
|
 |
|
| |
We are a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate and for which there is a clear demand for more effective pharmacotherapy, such as the introduction of our first-to-market generic stroke management medication Bicun and our anti-cancer medication Endu (also known as “Endostar").
We currently manufacture and sell more than 50
pharmaceutical products and are the
exclusive distributor of three additional
pharmaceutical products marketed under
our brand name. Our products range from
medications for the treatment of cancer,
cerebrovascular diseases, infections,
arthritis and diarrhea to medications
for the treatment of allergies, respiratory
conditions and urinary conditions. Our
credo "Respect People, Respect Life" demonstrates our commitment to high
standards of integrity in contributing
to the best interests of patients, the
medical profession, our employees and
our communities, and to seek significant
returns to our shareholders, based on
the continual pursuit of scientific
and operational excellence. |
|
|
|
|
 |
|
|
